Compare Ascendis Pharma A/S (ASND) vs Coursera Inc (COUR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Coursera Inc — how do they compare? Ascendis Pharma A/S trades at $254.01 (market cap $16.67B), while Coursera Inc trades at $5.65 (market cap $1.50B). The key difference: Ascendis Pharma A/S is far larger — about 11.1× Coursera Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals.
| ASND | COUR | |
|---|---|---|
Market Cap | $16.67B | $1.50B |
Sector | Health | Consumer Staples |
52-Week High | $277.18 | $12.20 |
52-Week Low | $189.74 | $5.09 |
Enterprise Value | $17.04B | $759.54M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →
